NCT01222975View on ClinicalTrials.gov

Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

December 31, 2004

Conditions
Healthy
Interventions
DRUG

Risperidone

orally disintegrating tablets

Trial Locations (1)

Unknown

aaiPharma Inc., Chapel Hill

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT01222975 - Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter